These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 15308814)

  • 21. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
    Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T
    Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of an antisense strategy to dissect the signaling role of protein-tyrosine phosphatase alpha.
    Arnott CH; Sale EM; Miller J; Sale GJ
    J Biol Chem; 1999 Sep; 274(37):26105-12. PubMed ID: 10473560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elucidating cell signaling mechanisms using antisense technology.
    Koller E; Gaarde WA; Monia BP
    Trends Pharmacol Sci; 2000 Apr; 21(4):142-8. PubMed ID: 10740290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNA interference for performance enhancement and detection in doping control.
    Kohler M; Schänzer W; Thevis M
    Drug Test Anal; 2011 Oct; 3(10):661-7. PubMed ID: 22031503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disruption of metabolic pathways--perspectives for the treatment of cancer.
    Araujo EP; Carvalheira JB; Velloso LA
    Curr Cancer Drug Targets; 2006 Feb; 6(1):77-87. PubMed ID: 16475977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Editorial: structure-function relationships of tyrosine kinase- and tyrosine phosphatase-linked receptors in platelets and megakaryocytes.
    Watson SP
    Platelets; 2021 Aug; 32(6):722-723. PubMed ID: 34053397
    [No Abstract]   [Full Text] [Related]  

  • 27. Structural requirements for the efficient regulation of the Src protein tyrosine kinase by Csk.
    Koegl M; Courtneidge SA; Superti-Furga G
    Oncogene; 1995 Dec; 11(11):2317-29. PubMed ID: 8570183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein kinase A-Ialpha subunit-directed antisense inhibition of ovarian cancer cell growth: crosstalk with tyrosine kinase signaling pathway.
    Alper O; Hacker NF; Cho-Chung YS
    Oncogene; 1999 Sep; 18(35):4999-5004. PubMed ID: 10490835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of antisense oligonucleotide technology to investigate signaling pathways in megakaryocytes.
    Avraham H; Avraham S; Zagozdzon R
    Methods Mol Biol; 2004; 273():397-406. PubMed ID: 15308814
    [No Abstract]   [Full Text] [Related]  

  • 30. Structure-function relationships in Src family and related protein tyrosine kinases.
    Superti-Furga G; Courtneidge SA
    Bioessays; 1995 Apr; 17(4):321-30. PubMed ID: 7537961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Src family of tyrosine protein kinases in hemopoietic signal transduction.
    Tsygankov A; Bolen J
    Stem Cells; 1993 Sep; 11(5):371-80. PubMed ID: 7694720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Signalling by the p60c-src family of protein-tyrosine kinases.
    Kefalas P; Brown TR; Brickell PM
    Int J Biochem Cell Biol; 1995 Jun; 27(6):551-63. PubMed ID: 7545532
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.